Pedro Beltran
Chief Scientific Officer, BridgeBio Oncology Therapeutics, Inc.
Companies
- BridgeBio Oncology Therapeutics, Inc.Board member May 5, 2026 to now1
- BridgeBio Oncology Therapeutics, Inc.Chief executive officer May 5, 2026 to now1
- BridgeBio Oncology Therapeutics, Inc.President May 5, 2026 to now1
- BridgeBio Oncology Therapeutics, Inc.Chief Scientific Officer Aug 18, 2025 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- BridgeBio Oncology Therapeutics, Inc. BBOT44,576 shares3$125.0K at $2.81Jul 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Shares withheld for tax 1,047 shares at $7.80 of BridgeBio Oncology Therapeutics, Inc.3
- Apr 1, 2026Shares withheld for tax 1,047 shares at $9.03 of BridgeBio Oncology Therapeutics, Inc.4
- Mar 10, 2026Granted 46,670 shares of BridgeBio Oncology Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 5, 2026
- 5SEC EDGARForm 4 filed Mar 12, 2026